- Report
- February 2025
- 200 Pages
Global
From €4186EUR$4,490USD£3,525GBP
- Report
- May 2025
- 638 Pages
Global
From €5453EUR$5,850USD£4,592GBP
- Report
- July 2024
- 200 Pages
Global
From €4613EUR$4,949USD£3,885GBP
- Book
- March 2009
- 384 Pages
The Egg Allergy market is a subset of the Allergy and Immunology market. Egg allergies are one of the most common food allergies, affecting up to 2% of children and 1% of adults. Symptoms of an egg allergy can range from mild to severe, and can include hives, swelling, and difficulty breathing. Diagnosis of an egg allergy is typically done through skin prick tests or blood tests. Treatment of an egg allergy is typically avoidance of eggs and egg-containing products, as well as the use of antihistamines and epinephrine auto-injectors.
Companies in the Egg Allergy market include Aimmune Therapeutics, DBV Technologies, and Allergenics. Aimmune Therapeutics is a biopharmaceutical company that develops treatments for food allergies, including egg allergies. DBV Technologies is a biopharmaceutical company that develops treatments for food allergies, including egg allergies. Allergenics is a biopharmaceutical company that develops treatments for food allergies, including egg allergies. Show Less Read more